Global Manufacturing of CAR T Cell Therapy von Levine, Bruce L, Miskin, James, Wonnacott, Keith, Keir, Christopher

Volltext

Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia von Mueller, Karen Thudium, Maude, Shannon L., Porter, David L., Frey, Noelle, Wood, Patricia, Han, Xia, Waldron, Edward, Chakraborty, Abhijit, Awasthi, Rakesh, Levine, Bruce L., Melenhorst, J. Joseph, Grupp, Stephan A., June, Carl H., Lacey, Simon F.

Volltext

Adoptive Immunotherapy for Cancer or Viruses von Maus, Marcela V, Fraietta, Joseph A, Levine, Bruce L, Kalos, Michael, Zhao, Yangbing, June, Carl H

Volltext

HER‐2 pulsed dendritic cell vaccine can eliminate HER‐2 expression and impact ductal carcinoma in situ von Sharma, Anupama, Koldovsky, Ursula, Xu, Shuwen, Mick, Rosemarie, Roses, Robert, Fitzpatrick, Elizabeth, Weinstein, Susan, Nisenbaum, Harvey, Levine, Bruce L., Fox, Kevin, Zhang, Paul, Koski, Gary, Czerniecki, Brian J.

Volltext

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma von Garfall, Alfred L., Dancy, Ehren K., Cohen, Adam D., Hwang, Wei-Ting, Fraietta, Joseph A., Davis, Megan M., Levine, Bruce L., Siegel, Don L., Stadtmauer, Edward A., Vogl, Dan T., Waxman, Adam, Rapoport, Aaron P., Milone, Michael C., June, Carl H., Melenhorst, J. Joseph

Volltext

CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success von Long, Kristen B, Young, Regina M, Boesteanu, Alina C, Davis, Megan M, Melenhorst, J Joseph, Lacey, Simon F, DeGaramo, David A, Levine, Bruce L, Fraietta, Joseph A

Volltext

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells von Stein, Andrew M., Grupp, Stephan A., Levine, John E., Laetsch, Theodore W., Pulsipher, Michael A., Boyer, Michael W., August, Keith J., Levine, Bruce L., Tomassian, Lori, Shah, Sweta, Leung, Mimi, Huang, Pai‐Hsi, Awasthi, Rakesh, Mueller, Karen Thudium, Wood, Patricia A., June, Carl H.

Volltext

Engineered T cells: the promise and challenges of cancer immunotherapy von Fesnak, Andrew D., June, Carl H., Levine, Bruce L.

Volltext

The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19 von Braendstrup, Peter, Levine, Bruce L., Ruella, Marco

Volltext

A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies von WANG, KAN, LIU, YI, LI, JUNXUAN, WANG, BEN, BISHOP, REID, WHITE, CHIP, DAS, AMRITAVA, LEVINE, AARON D, HO, LINDA, LEVINE, BRUCE L, FESNAK, ANDREW D

Volltext

Gene Transfer in Humans Using a Conditionally Replicating Lentiviral Vector von Levine, Bruce L., Humeau, Laurent M., Boyer, Jean, MacGregor, Rob-Roy, Rebello, Tessio, Lu, Xiaobin, Binder, Gwendolyn K., Slepushkin, Vladimir, Lemiale, Franck, Mascola, John R., Bushman, Frederic D., Dropulic, Boro, June, Carl H.

Volltext

Exploring synthetic immunity: From boutique to global von Levine, Bruce L.

Volltext

Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection von EBINUMA, Hirotoshi, NAKAMOTO, Nobuhiro, YUN LI, PRICE, David A, GOSTICK, Emma, LEVINE, Bruce L, TOBIAS, J, KWOK, William W, CHANG, Kyong-Mi

Volltext

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia von Porter, David L, Levine, Bruce L, Kalos, Michael, Bagg, Adam, June, Carl H

Volltext

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas von Schuster, Stephen J, Svoboda, Jakub, Chong, Elise A, Nasta, Sunita D, Mato, Anthony R, Anak, Özlem, Brogdon, Jennifer L, Pruteanu-Malinici, Iulian, Bhoj, Vijay, Landsburg, Daniel, Wasik, Mariusz, Levine, Bruce L, Lacey, Simon F, Melenhorst, Jan J, Porter, David L, June, Carl H

Volltext

CAR T-cell product performance in haematological malignancies before and after marketing authorisation von Elsallab, Magdi, Levine, Bruce L, Wayne, Alan S, Abou-El-Enein, Mohamed

Volltext

Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1 von Amarnath, Shoba, Costanzo, Carliann M, Mariotti, Jacopo, Ullman, Jessica L, Telford, William G, Kapoor, Veena, Riley, James L, Levine, Bruce L, June, Carl H, Fong, Timothy, Warner, Noel L, Fowler, Daniel H

Volltext

Decade-long leukaemia remissions with persistence of CD4+ CAR T cells von Melenhorst, J. Joseph, Chen, Gregory M., Wang, Meng, Porter, David L., Chen, Changya, Collins, McKensie A., Gao, Peng, Bandyopadhyay, Shovik, Sun, Hongxing, Zhao, Ziran, Lundh, Stefan, Pruteanu-Malinici, Iulian, Nobles, Christopher L., Maji, Sayantan, Frey, Noelle V., Gill, Saar I., Loren, Alison W., Tian, Lifeng, Kulikovskaya, Irina, Gupta, Minnal, Ambrose, David E., Davis, Megan M., Fraietta, Joseph A., Brogdon, Jennifer L., Young, Regina M., Chew, Anne, Levine, Bruce L., Siegel, Donald L., Alanio, Cécile, Wherry, E. John, Bushman, Frederic D., Lacey, Simon F., Tan, Kai, June, Carl H.

Volltext

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes von Ye, Qunrui, Loisiou, Maria, Levine, Bruce L, Suhoski, Megan M, Riley, James L, June, Carl H, Coukos, George, Powell, Jr, Daniel J

Volltext

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma von Cohen, Adam D, Garfall, Alfred L, Stadtmauer, Edward A, Melenhorst, J Joseph, Lacey, Simon F, Lancaster, Eric, Vogl, Dan T, Weiss, Brendan M, Dengel, Karen, Nelson, Annemarie, Plesa, Gabriela, Chen, Fang, Davis, Megan M, Hwang, Wei-Ting, Young, Regina M, Brogdon, Jennifer L, Isaacs, Randi, Pruteanu-Malinici, Iulian, Siegel, Don L, Levine, Bruce L, June, Carl H, Milone, Michael C

Volltext